{
  "id": 8012872,
  "title": "US Medicare Pricing Policies Could Drive Global Costs and Hinder Access Worldwide",
  "url": "https://urgent.news/2026/09/17/us-medicare-pricing-policies-could-drive-global-costs-and-hinder-8012872",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-17T10:15:21.000Z",
  "source": {
    "name": "Health Policy Watch",
    "slug": "health-policy-watch",
    "url": "https://healthpolicy-watch.news/us-medicare-pricing-policies-could-drive-global-costs-and-hinder-access-worldwide/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A new modelling study suggests that US Medicare “Most-Favored-Nation” policies on drug prices would cut Medicare spending on brand name drugs, but potentially incentivize companies to increase prices or delay new drug launches elsewhere. Efforts to control the cost of United States government spending on drugs culminated in a “most-favored-nation” policy, a Trump administration initiative […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Health Policy Watch",
        "title": "US Medicare Pricing Policies Could Drive Global Costs and Hinder Access Worldwide",
        "url": "https://urgent.news/2026/09/17/us-medicare-pricing-policies-could-drive-global-costs-and-hinder",
        "published": "2026-09-17T10:15:21.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}